Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Suppression of Human Platelet Activation via Integrin αIIbβ3 Outside-In Independent Signal and Reduction of the Mortality in Pulmonary Thrombosis by Auraptene.

Hsia CW, Tsai CL, Sheu JR, Lu WJ, Hsia CH, Velusamy M, Jayakumar T, Li JY.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5585. doi: 10.3390/ijms20225585.

2.

Pyrene-Based Chemosensor for Picric Acid-Fundamentals to Smartphone Device Design.

Kathiravan A, Gowri A, Khamrang T, Kumar MD, Dhenadhayalan N, Lin KC, Velusamy M, Jaccob M.

Anal Chem. 2019 Oct 15;91(20):13244-13250. doi: 10.1021/acs.analchem.9b03695. Epub 2019 Sep 30.

PMID:
31542920
3.

Catalytic Conversion of Atmospheric CO2 into Organic Carbonates by Nickel(II) Complexes of Diazepane-Based N4 Ligands.

Muthuramalingam S, Sankaralingam M, Velusamy M, Mayilmurugan R.

Inorg Chem. 2019 Oct 7;58(19):12975-12985. doi: 10.1021/acs.inorgchem.9b01908. Epub 2019 Sep 19.

PMID:
31535857
4.

Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2-PKC-AKT Activation in Human Platelets.

Hsia CW, Lin KC, Lee TY, Hsia CH, Chou DS, Jayakumar T, Velusamy M, Chang CC, Sheu JR.

Int J Mol Sci. 2019 Jun 3;20(11). pii: E2731. doi: 10.3390/ijms20112731.

5.

Ruthenium complex, TQ‑5, protects against LPS‑induced macrophage inflammation and acute liver injury in mice via downregulating NF‑κB pathways.

Hou SM, Hsia CH, Velusamy M, Jayakumar T, Hsia CW, Chang CC, Lin KH, Lu YC.

Int J Mol Med. 2019 Jul;44(1):335-345. doi: 10.3892/ijmm.2019.4179. Epub 2019 May 3.

PMID:
31059066
6.

[Corrigendum] Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.

Shyu KG, Velusamy M, Hsia CW, Yang CH, Hsia CH, Chou DS, Jayakumar T, Sheu JR, Li JY.

Int J Mol Med. 2019 Jul;44(1):357. doi: 10.3892/ijmm.2019.4177. Epub 2019 Apr 30.

7.

Coordination geometry-induced optical imaging of l-cysteine in cancer cells using imidazopyridine-based copper(ii) complexes.

Priyanga S, Khamrang T, Velusamy M, Karthi S, Ashokkumar B, Mayilmurugan R.

Dalton Trans. 2019 Jan 28;48(4):1489-1503. doi: 10.1039/c8dt04634d. Epub 2019 Jan 11.

PMID:
30632585
8.
9.

Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate.

Hsia CW, Wu MP, Velusamy M, Hsia CH, Chou DS, Tsai CL, Hsu CY, Jayakumar T, Chung CL, Sheu JR.

Int J Mol Sci. 2018 Aug 13;19(8). pii: E2386. doi: 10.3390/ijms19082386.

10.

Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation.

Shyu RS, Khamrang T, Sheu JR, Hsia CW, Velusamy M, Hsia CH, Chou DS, Chang CC.

Bioinorg Chem Appl. 2018 May 2;2018:8291393. doi: 10.1155/2018/8291393. eCollection 2018.

11.

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets.

Hsia CH, Jayakumar T, Sheu JR, Tsao SY, Velusamy M, Hsia CW, Chou DS, Chang CC, Chung CL, Khamrang T, Lin KC.

Molecules. 2018 Feb 22;23(2). pii: E477. doi: 10.3390/molecules23020477.

12.

Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.

Shyu KG, Velusamy M, Hsia CW, Yang CH, Hsia CH, Chou DS, Jayakumar T, Sheu JR, Li JY.

Int J Mol Med. 2018 May;41(5):2589-2600. doi: 10.3892/ijmm.2018.3472. Epub 2018 Feb 7. Erratum in: Int J Mol Med. 2019 Jul;44(1):357.

13.

A combined experimental and computational investigation on pyrene based D-π-A dyes.

Khamrang T, Velusamy M, Jaccob M, Ramesh M, Kathiresan M, Kathiravan A.

Phys Chem Chem Phys. 2018 Feb 28;20(9):6264-6273. doi: 10.1039/c7cp08038g.

PMID:
29431799
14.

New Therapeutic Agent against Arterial Thrombosis: An Iridium(III)-Derived Organometallic Compound.

Hsia CW, Velusamy M, Tsao JT, Hsia CH, Chou DS, Jayakumar T, Lee LW, Li JY, Sheu JR.

Int J Mol Sci. 2017 Dec 5;18(12). pii: E2616. doi: 10.3390/ijms18122616.

15.

Catalytic fixation of atmospheric carbon dioxide by copper(ii) complexes of bidentate ligands.

Muthuramalingam S, Khamrang T, Velusamy M, Mayilmurugan R.

Dalton Trans. 2017 Nov 28;46(46):16065-16076. doi: 10.1039/c7dt03062b.

PMID:
29119984
16.

A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.

Hsia CH, Velusamy M, Sheu JR, Khamrang T, Jayakumar T, Lu WJ, Lin KH, Chang CC.

Sci Rep. 2017 Aug 25;7(1):9556. doi: 10.1038/s41598-017-09695-z.

17.

Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.

Khamrang T, Hung KC, Hsia CH, Hsieh CY, Velusamy M, Jayakumar T, Sheu JR.

Int J Mol Sci. 2017 Apr 27;18(5). pii: E916. doi: 10.3390/ijms18050916.

18.

Pyrene based D-π-A architectures: synthesis, density functional theory, photophysics and electron transfer dynamics.

Kathiravan A, Srinivasan V, Khamrang T, Velusamy M, Jaccob M, Pavithra N, Anandan S, Velappan K.

Phys Chem Chem Phys. 2017 Jan 25;19(4):3125-3135. doi: 10.1039/c6cp08180k.

PMID:
28083594
19.

Time-resolved neutron reflectometry and photovoltaic device studies on sequentially deposited PCDTBT-fullerene layers.

Clulow AJ, Tao C, Lee KH, Velusamy M, McEwan JA, Shaw PE, Yamada NL, James M, Burn PL, Gentle IR, Meredith P.

Langmuir. 2014 Sep 30;30(38):11474-84. doi: 10.1021/la5020779. Epub 2014 Sep 15.

PMID:
25222029
20.

Determination of fullerene scattering length density: a critical parameter for understanding the fullerene distribution in bulk heterojunction organic photovoltaic devices.

Clulow AJ, Armin A, Lee KH, Pandey AK, Tao C, Velusamy M, James M, Nelson A, Burn PL, Gentle IR, Meredith P.

Langmuir. 2014 Feb 11;30(5):1410-5. doi: 10.1021/la403951j. Epub 2014 Jan 27.

PMID:
24467334

Supplemental Content

Loading ...
Support Center